Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:19 PM
Ignite Modification Date:
2025-12-24 @ 10:19 PM
NCT ID:
NCT03234335
Eligibility Criteria:
Inclusion Criteria:
* Age ≤ 66 years-old
* Patients with symptomatic, measurable and newly diagnosed multiple myeloma associated:
* Severe renal failure at the time of transplantation (creatinine clearance \< 40 ml/min/1.73m², CKD-EPI: Chronic Kidney Disease Epidemiology Collaboration)
* Partial response after induction treatment
* For patients who undergo autologous transplantation, absence of known contraindication for transplantation
* Absence of amylose
* Patient affiliated to a social security regimen or beneficiary of the same
* Signed written informed consent form
Exclusion Criteria:
* Patient without at least a partial hematological response following the induction stage
* Medical history of previous malignancy
* Patient under guardianship or deprived of his liberty or any condition that may affect the patient's ability to understand and sign the informed consent (art. L.1121-6, L.112-7, L.1211-8, L.1211-9)
* Pregnant or breastfeeding woman
* Declining participation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
66 Years
Study:
NCT03234335
Study Brief:
Protocol Section:
NCT03234335